Altaris invests in companies that operate across the healthcare continuum, including the pharmaceuticals, medical devices, healthcare services and healthcare IT sectors. We target businesses with strong management teams that are generating revenue and positive cash flow, and that will benefit from our expertise and network of relationships within the healthcare industry. In analyzing investment prospects, our primary focus is on sector dynamics and business fundamentals, including historical financial performance and prospects for profitable growth, whether organic or through acquisitions.

Most of our portfolio companies have one or more of the following characteristics:

• Strong intellectual property;
• Industry transforming business models;
• Value investing characteristics.

We make control and significant minority investments that typically range in size from $15-50 million of equity. Our investment approach is flexible and creative, but the most common types of transactions in which we participate include:

• Corporate carve-outs;
• Leveraged buyouts;
• Growth equity/recapitalization investments.